SARS-CoV-2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment.

McDermid, Andrew; Lam, Kaitlyn; Ko, Yen Chen Kevin; Schmitt, Toby; Khosravi-Hafshejani, Touraj; Dutz, Jan P

SARS-CoV-2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment.

McDermid, Andrew; Lam, Kaitlyn; Ko, Yen Chen Kevin; Schmitt, Toby; Khosravi-Hafshejani, Touraj; Dutz, Jan P.

Affiliation

McDermid A; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada.
Lam K; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada.
Ko YCK; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Schmitt T; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Khosravi-Hafshejani T; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada.
Dutz JP; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada.

J Dtsch Dermatol Ges ; 22(7): 1013-1015, 2024 Jul.

Article in En | MEDLINE | ID: mdl-38837589

Subject(s)
Key words

COVID; RIME; T cell; calcineurin inhibitor

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cyclosporine / SARS-CoV-2 / COVID-19 / Immunosuppressive Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Dtsch Dermatol Ges / J. Dtsch. Dermatol. Ges / Journal der Deutschen Dermatologischen Gesellschaft Journal subject: DERMATOLOGIA Year: 2024 Document type: Article Affiliation country: Canadá Country of publication: Alemania

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google